Altimmune Inc (ALT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2013 | 12-2012 | 12-2011 | 12-2010 | 12-2009 | |
| Sales | 17,913 | 25,176 | 24,266 | 20,994 | 27,550 |
| Gross Profit | 17,913 | 25,176 | 24,266 | 20,994 | 27,550 |
| Operating Expenses | 28,752 | 31,442 | 35,992 | 44,547 | 53,525 |
| Operating Income | -10,839 | -6,266 | -11,726 | -23,554 | -25,975 |
| Interest Expense | 367 | 325 | 55 | 5,937 | 2,837 |
| Other Income | -451 | 1,867 | 7,983 | -5,359 | -3,468 |
| Pre-tax Income | -11,657 | -4,725 | -3,798 | -34,849 | -32,280 |
| Income Tax | 62 | 196 | N/A | N/A | N/A |
| Net Income Continuous | -11,718 | -4,920 | -3,798 | -34,849 | -32,280 |
| Net Income | $-11,718 | $-4,920 | $-3,798 | $-34,849 | $-32,280 |
| EPS Basic Total Ops | -69.07 | -30.03 | -24.02 | -324.32 | -351.35 |
| EPS Basic Continuous Ops | -69.46 | -30.58 | -24.09 | -323.90 | -351.54 |
| EPS Diluted Total Ops | -69.07 | -30.03 | -24.02 | -324.32 | -351.35 |
| EPS Diluted Continuous Ops | -69.46 | -30.58 | -24.09 | -323.90 | -351.54 |
| EBITDA(a) | $-10,657 | $-5,963 | $-11,265 | $-22,533 | $-25,102 |